In this study, Feng et al. show that when DUX4 isactivated following the failure of epigenetic control in FSHD patients, theeffectiveness of nonsense-mediated decay is also reduced. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.